Developer docs
API playgroundTry for free, no card

Search company profiles

BlueReg Group

Full company profile

uuid000ekqf

Namestring
BlueReg Group
Websiteurl
blue-reg.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

BlueReg Group is a private, Paris-headquartered consulting firm founded in 2011 that delivers specialized services to the pharmaceutical industry across five core practice areas: development, regulatory affairs, economic affairs, quality, and pharmacovigilance. With a headcount of 101–250 employees, the firm operates as a mid-size European regulatory and drug development consultancy, serving clients that require expert navigation of EMA/FDA-grade regulatory processes, market access strategy, health economics, and product safety monitoring.

The firm's service portfolio maps to the full pharmaceutical product lifecycle — from clinical development and submissions through post-approval maintenance, pharmacovigilance operations (including QPPV services, signal detection, and adverse event processing), health economics and outcomes research, and quality/compliance management. The combined PharmaLex-aligned content bundled into the input suggests BlueReg may operate within or adjacent to the broader Cencora/PharmaLex ecosystem, though this relationship is not explicitly confirmed in any BlueReg-attributed statement in the data.

Business model mechanics are not disclosed in the source material. As a specialized consulting firm with 101–250 employees, the implied model is a hybrid of project-based regulatory submissions, retained pharmacovigilance/FTE contracts, and advisory engagements priced on a time-and-materials or milestone basis — typical of mid-market European pharma consultancies. No pricing details, GTM motion descriptors, named customers, or revenue figures are provided in the input.

Short descriptiontext

BlueReg Group is a Paris-based pharmaceutical consulting firm (founded 2011, 101–250 employees) specializing in regulatory affairs, drug development, economic affairs, quality, and pharmacovigilance services for pharma and biotech clients.

Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersCourbevoie, France
HQ citystring
Courbevoie
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
regulatory affairs consulting, pharmaceutical development consulting, pharmacovigilance services, quality assurance consulting, pharma regulatory strategy
Industry1 code
PRIMARYHLAGAKAE
GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code1 code
  • Management Consulting Services54161
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Regulatory Consulting
Social media profiles2 records
Cost components2 values
Personnel, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BlueReg Group is a consulting firm that provides specialized services in pharmaceutical development, regulatory affairs, economic affairs, quality, and pharmacovigilance. The company serves pharmaceutical, biotechnology, and medical device industry clients with consulting support across the product lifecycle, from development through post-market activities.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Pharmaceutical Development Consulting
Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global testing and life sciences services group with regulatory and pharma product testing capabilities, including GMP/GLP compliance services that intersect with BlueReg's quality offering.

TypeBroad incumbent
Description

Largest global CRO offering regulatory affairs and pharmacovigilance services as part of a full clinical and commercial platform; competes with BlueReg on bundled regulatory and R&D engagements.

TypeBroad incumbent
Description

Major global CRO with substantial regulatory consulting and pharmacovigilance practices; relevant as a broad competitor in regulatory affairs services for pharma and biotech sponsors.

TypeBroad incumbent
Description

Global CRO (post-PRA Health Sciences) with dedicated regulatory and pharmacovigilance capabilities; competes with BlueReg on larger multi-functional programs requiring regulatory expertise.

TypeEmerging player
Description

Specialized pharma regulatory and quality consulting firm with overlap in CMC, regulatory affairs, and pharmacovigilance services; comparable as a niche European-headquartered consultancy.

TypeBroad incumbent
Description

Global CRO/CDMO with a regulatory and quality consulting practice serving pharma and biotech; competes with BlueReg on regulatory affairs and quality compliance engagements.

TypeDirect peer
Description

Cencora-owned specialized pharma services provider offering regulatory affairs, CMC, pharmacovigilance, and market access — directly overlapping BlueReg's core service lines of regulatory affairs, quality, and pharmacovigilance.

TypeDirect peer
Description

European-based regulatory affairs and drug development consultancy serving pharma and biotech; comparable in size, geography, and service mix to BlueReg, particularly around submission strategy and health authority interactions.

TypeDirect peer
Description

Paris-headquartered regulatory and health economics consultancy covering product development, regulatory affairs, and market access — a direct French-headquartered competitor with an overlapping service portfolio.

TypeBroad incumbent
Description

Global life sciences services division of SGS offering GxP audits, quality compliance, and regulatory consulting — directly comparable to BlueReg's quality and GxP audit work.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BlueReg Group

Pharmaceutical Regulatory Consultingblue-reg.com

BlueReg Group is a Paris-based pharmaceutical consulting firm (founded 2011, 101–250 employees) specializing in regulatory affairs, drug development, economic affairs, quality, and pharmacovigilance services for pharma and biotech clients.

What BlueReg Group does

BlueReg Group is a private, Paris-headquartered consulting firm founded in 2011 that delivers specialized services to the pharmaceutical industry across five core practice areas: development, regulatory affairs, economic affairs, quality, and pharmacovigilance. With a headcount of 101–250 employees, the firm operates as a mid-size European regulatory and drug development consultancy, serving clients that require expert navigation of EMA/FDA-grade regulatory processes, market access strategy, health economics, and product safety monitoring.

The firm's service portfolio maps to the full pharmaceutical product lifecycle — from clinical development and submissions through post-approval maintenance, pharmacovigilance operations (including QPPV services, signal detection, and adverse event processing), health economics and outcomes research, and quality/compliance management. The combined PharmaLex-aligned content bundled into the input suggests BlueReg may operate within or adjacent to the broader Cencora/PharmaLex ecosystem, though this relationship is not explicitly confirmed in any BlueReg-attributed statement in the data.

Business model mechanics are not disclosed in the source material. As a specialized consulting firm with 101–250 employees, the implied model is a hybrid of project-based regulatory submissions, retained pharmacovigilance/FTE contracts, and advisory engagements priced on a time-and-materials or milestone basis — typical of mid-market European pharma consultancies. No pricing details, GTM motion descriptors, named customers, or revenue figures are provided in the input.

BlueReg Group firmographics

Firmographics
Name
BlueReg Group
Website
https://blue-reg.com
Company type
Private
Founded year
2015
Headcount range
101–250 employees
Short description
BlueReg Group is a Paris-based pharmaceutical consulting firm (founded 2011, 101–250 employees) specializing in regulatory affairs, drug development, economic affairs, quality, and pharmacovigilance services for pharma and biotech clients.
Ownership category
akta.pro rank

BlueReg Group industry classification

Industry
Product category
Pharmaceutical Regulatory Consulting
NAICS
Management Consulting Services (54161)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAKAE
GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Regulatory affairs consulting
  • Pharmaceutical development consulting
  • Pharmacovigilance services
  • Quality assurance consulting
  • Pharma regulatory strategy

Where BlueReg Group is headquartered

Location

Headquarters

HQ city
Courbevoie
HQ country
France
HQ region
Europe

Markets served

BlueReg Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations

BlueReg Group product offering

Product offering

Core offering

BlueReg Group is a consulting firm that provides specialized services in pharmaceutical development, regulatory affairs, economic affairs, quality, and pharmacovigilance. The company serves pharmaceutical, biotechnology, and medical device industry clients with consulting support across the product lifecycle, from development through post-market activities.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Development Consulting

Companies that use BlueReg Group

Customer profile

Ideal customer profiles1 record

BlueReg Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BlueReg Group partnerships and signals

Strategic signal

Expansion highlights2 records

BlueReg Group competitors and assessment

Company assessment

Broad incumbents

  • Eurofins Scientific: Global testing and life sciences services group with regulatory and pharma product testing capabilities, including GMP/GLP compliance services that intersect with BlueReg's quality offering.
  • IQVIA: Largest global CRO offering regulatory affairs and pharmacovigilance services as part of a full clinical and commercial platform; competes with BlueReg on bundled regulatory and R&D engagements.
  • Parexel: Major global CRO with substantial regulatory consulting and pharmacovigilance practices; relevant as a broad competitor in regulatory affairs services for pharma and biotech sponsors.
  • ICON plc: Global CRO (post-PRA Health Sciences) with dedicated regulatory and pharmacovigilance capabilities; competes with BlueReg on larger multi-functional programs requiring regulatory expertise.
  • Charles River Laboratories: Global CRO/CDMO with a regulatory and quality consulting practice serving pharma and biotech; competes with BlueReg on regulatory affairs and quality compliance engagements.
  • SGS Health Science: Global life sciences services division of SGS offering GxP audits, quality compliance, and regulatory consulting — directly comparable to BlueReg's quality and GxP audit work.

Emerging players

  • Pharma Wizard: Specialized pharma regulatory and quality consulting firm with overlap in CMC, regulatory affairs, and pharmacovigilance services; comparable as a niche European-headquartered consultancy.

Direct peers

  • Cencora PharmaLex: Cencora-owned specialized pharma services provider offering regulatory affairs, CMC, pharmacovigilance, and market access — directly overlapping BlueReg's core service lines of regulatory affairs, quality, and pharmacovigilance.
  • NDA Group: European-based regulatory affairs and drug development consultancy serving pharma and biotech; comparable in size, geography, and service mix to BlueReg, particularly around submission strategy and health authority interactions.
  • Voisin Consulting Life Sciences (VCLS): Paris-headquartered regulatory and health economics consultancy covering product development, regulatory affairs, and market access — a direct French-headquartered competitor with an overlapping service portfolio.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat3 records

Key risks4 records

Key highlights4 records

Customer concentration

BlueReg Group social profiles

Digital presence

BlueReg Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BlueReg Group leadership team

Management profile

Number of profiles

BlueReg Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BlueReg Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlueReg Group

What does BlueReg Group do?

BlueReg Group is a consulting firm that provides specialized services in pharmaceutical development, regulatory affairs, economic affairs, quality, and pharmacovigilance. The company serves pharmaceutical, biotechnology, and medical device industry clients with consulting support across the product lifecycle, from development through post-market activities.

When was BlueReg Group founded?

BlueReg Group was founded in 2015. It employs 101 to 250 people.

Where is BlueReg Group based?

BlueReg Group is headquartered in Courbevoie, France, in the Europe region.

Who are BlueReg Group's main competitors?

Broad incumbents on record are Eurofins Scientific, IQVIA, Parexel, ICON plc, Charles River Laboratories and SGS Health Science. Pharma Wizard is listed as an emerging player. Direct peers are Cencora PharmaLex, NDA Group and Voisin Consulting Life Sciences (VCLS).

Does BlueReg Group have an API?

No public API is recorded for BlueReg Group.

What industry is BlueReg Group in?

BlueReg Group's product category is Pharmaceutical Regulatory Consulting. Its primary akta.pro industry code is HLAGAKAE, GxP Audits & Supplier Qualification (GMP/GCP/GLP/GDP). Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals